OAC
CRBP icon

OMERS Administration Corp’s Corbus Pharmaceuticals CRBP Stock Holding History

OMERS Administration Corp’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,200
Closed -$143K – 969
2026
Q1 		$143K Sell
15,200
-14,800
-49% -$125K ﹤0.01% 969
2025
Q4 		$244K Buy
+30,000
New +$370K ﹤0.01% 865

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

OMERS Administration Corp's CRBP Position: Q2 2026 in Review

OMERS Administration Corp sold out of Corbus Pharmaceuticals (CRBP) in Q2 2026, closing a stake of 15,200 shares — an estimated $143K sold.

OMERS Administration Corp first reported a position in CRBP in Q4 2025 and held it in 2 quarters. The position peaked at $244K in Q4 2025. 107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • OMERS Administration Corp reported no remaining Corbus Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • OMERS Administration Corp sold 15,200 Corbus Pharmaceuticals shares in Q2 2026, an estimated $143K.
  • OMERS Administration Corp first reported a position in Corbus Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • OMERS Administration Corp's Corbus Pharmaceuticals position peaked at $244K in Q4 2025.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.